Eckert & Ziegler SE (ETR:EUZ)
60.40
-1.00 (-1.63%)
Feb 21, 2025, 5:05 PM CET
Eckert & Ziegler SE Employees
Eckert & Ziegler SE had 1,075 employees as of December 31, 2023. The number of employees increased by 99 or 10.14% compared to the previous year.
Employees
1,075
Change (1Y)
99
Growth (1Y)
10.14%
Revenue / Employee
€242,976
Profits / Employee
€25,709
Market Cap
1.26B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 62,908 |
Bayer Aktiengesellschaft | 96,931 |
Fresenius SE & Co. KGaA | 193,865 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 119,845 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
Eckert & Ziegler SE News
- 9 days ago - EQS-Adhoc: Eckert & Ziegler Affected by Cyber Attack - Wallstreet:Online
- 5 weeks ago - EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture - Wallstreet:Online
- 5 weeks ago - EQS-News: Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments - Wallstreet:Online
- 2 months ago - EQS-News: Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply - Wallstreet:Online
- 3 months ago - EQS-News: Eckert & Ziegler Achieves European Approval for Theralugand - Lutetium-177 Chloride (n.c.a) - Wallstreet:Online
- 3 months ago - Eckert & Ziegler Boosts Financial Year Forecast Again! - Wallstreet:Online